Terms: = Lung cancer AND EIF3E, eIF3-p46, 3646, ENSG00000104408, EIF3S6, eIF3e, EIF3-P48, INT6
20 results:
1. int6/eif3e represses E-cadherin expression through HIF2α in lung carcinoma A549 cells.
Gotoh-Saito S; Sadato D; Shibasaki F
Genes Cells; 2022 Dec; 27(12):689-705. PubMed ID: 36116043
[TBL] [Abstract] [Full Text] [Related]
2. MicroRNA miR-3646 promotes malignancy of lung adenocarcinoma cells by suppressing sorbin and SH3 domain-containing protein 1 via the c-Jun NH2-terminal kinase signaling pathway.
Wang C; Cheng B
Bioengineered; 2022 Mar; 13(3):4869-4884. PubMed ID: 35196185
[TBL] [Abstract] [Full Text] [Related]
3. Origin of the T790M mutation and its impact on the clinical outcomes of patients with lung adenocarcinoma receiving EGFR-TKIs.
Dong Y; Zhou Z; Wang J; Ma L; Liu Z; Wang Y; Song J; Zhang S; Che N
Pathol Res Pract; 2019 May; 215(5):946-951. PubMed ID: 30760406
[TBL] [Abstract] [Full Text] [Related]
4. A pan-cancer study of copy number gain and up-regulation in human oncogenes.
Wee Y; Wang T; Liu Y; Li X; Zhao M
Life Sci; 2018 Oct; 211():206-214. PubMed ID: 30243646
[TBL] [Abstract] [Full Text] [Related]
5. lung metastases from benign uterine leiomyoma: does 18-FDG-PET/CT have a role to play?
Abu Saadeh F; Riain CO; Cormack CM; Gleeson N
Ir J Med Sci; 2019 May; 188(2):619-624. PubMed ID: 30074141
[TBL] [Abstract] [Full Text] [Related]
6. Allogeneic Human Double Negative T Cells as a Novel Immunotherapy for Acute Myeloid Leukemia and Its Underlying Mechanisms.
Lee J; Minden MD; Chen WC; Streck E; Chen B; Kang H; Arruda A; Ly D; Der SD; Kang S; Achita P; D'Souza C; Li Y; Childs RW; Dick JE; Zhang L
Clin Cancer Res; 2018 Jan; 24(2):370-382. PubMed ID: 29074605
[No Abstract] [Full Text] [Related]
7. Impact of patient selection and treatment strategies on outcomes after lobectomy for biopsy-proven stage IIIA pN2 non-small cell lung cancer.
Yang CF; Adil SM; Anderson KL; Meyerhoff RR; Turley RS; Hartwig MG; Harpole DH; Tong BC; Onaitis MW; D'Amico TA; Berry MF
Eur J Cardiothorac Surg; 2016 Jun; 49(6):1607-13. PubMed ID: 26719403
[TBL] [Abstract] [Full Text] [Related]
8. Decreased eif3e Expression Can Mediate Epithelial-to-Mesenchymal Transition through Activation of the TGFβ Signaling Pathway.
Desnoyers G; Frost LD; Courteau L; Wall ML; Lewis SM
Mol Cancer Res; 2015 Oct; 13(10):1421-30. PubMed ID: 26056130
[TBL] [Abstract] [Full Text] [Related]
9. Effect of previous history of cancer on survival of patients with a second cancer of the head and neck.
Jégu J; Belot A; Borel C; Daubisse-Marliac L; Trétarre B; Ganry O; Guizard AV; Bara S; Troussard X; Bouvier V; Woronoff AS; Colonna M; Velten M
Oral Oncol; 2015 May; 51(5):457-63. PubMed ID: 25687113
[TBL] [Abstract] [Full Text] [Related]
10. Aberrant RSPO3-LGR4 signaling in Keap1-deficient lung adenocarcinomas promotes tumor aggressiveness.
Gong X; Yi J; Carmon KS; Crumbley CA; Xiong W; Thomas A; Fan X; Guo S; An Z; Chang JT; Liu QJ
Oncogene; 2015 Sep; 34(36):4692-701. PubMed ID: 25531322
[TBL] [Abstract] [Full Text] [Related]
11. RSPO fusion transcripts in colorectal cancer in Japanese population.
Shinmura K; Kahyo T; Kato H; Igarashi H; Matsuura S; Nakamura S; Kurachi K; Nakamura T; Ogawa H; Funai K; Tanahashi M; Niwa H; Sugimura H
Mol Biol Rep; 2014 Aug; 41(8):5375-84. PubMed ID: 24847761
[TBL] [Abstract] [Full Text] [Related]
12. The safety and efficacy of EGFR TKIs monotherapy versus single-agent chemotherapy using third-generation cytotoxics as the first-line treatment for patients with advanced non-small cell lung cancer and poor performance status.
Liu S; Wang D; Chen B; Wang Y; Zhao W; Wu J
Lung Cancer; 2011 Aug; 73(2):203-10. PubMed ID: 21211862
[TBL] [Abstract] [Full Text] [Related]
13. Effect of nodule characteristics on variability of semiautomated volume measurements in pulmonary nodules detected in a lung cancer screening program.
Wang Y; van Klaveren RJ; van der Zaag-Loonen HJ; de Bock GH; Gietema HA; Xu DM; Leusveld AL; de Koning HJ; Scholten ET; Verschakelen J; Prokop M; Oudkerk M
Radiology; 2008 Aug; 248(2):625-31. PubMed ID: 18641255
[TBL] [Abstract] [Full Text] [Related]
14. Expression of eif3-p48/int6, TID1 and Patched in cancer, a profiling of multiple tumor types and correlation of expression.
Traicoff JL; Chung JY; Braunschweig T; Mazo I; Shu Y; Ramesh A; D'Amico MW; Galperin MM; Knezevic V; Hewitt SM
J Biomed Sci; 2007 May; 14(3):395-405. PubMed ID: 17385060
[TBL] [Abstract] [Full Text] [Related]
15. Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic.
Ranieri G; Patruno R; Ruggieri E; Montemurro S; Valerio P; Ribatti D
Curr Med Chem; 2006; 13(16):1845-57. PubMed ID: 16842197
[TBL] [Abstract] [Full Text] [Related]
16. int6 expression can predict survival in early-stage non-small cell lung cancer patients.
Buttitta F; Martella C; Barassi F; Felicioni L; Salvatore S; Rosini S; D'Antuono T; Chella A; Mucilli F; Sacco R; Mezzetti A; Cuccurullo F; Callahan R; Marchetti A
Clin Cancer Res; 2005 May; 11(9):3198-204. PubMed ID: 15867213
[TBL] [Abstract] [Full Text] [Related]
17. Reduced expression of INT-6/eif3-p48 in human tumors.
Marchetti A; Buttitta F; Pellegrini S; Bertacca G; Callahan R
Int J Oncol; 2001 Jan; 18(1):175-9. PubMed ID: 11115556
[TBL] [Abstract] [Full Text] [Related]
18. The influence of gemcitabine and cisplatin schedule on response and survival in advanced non-small cell lung cancer.
Shepherd FA; Abratt R; Crino L; Green M; Sandler A; Steward W; Iglesias J; Anglin G
Lung Cancer; 2000 Nov; 30(2):117-25. PubMed ID: 11086205
[TBL] [Abstract] [Full Text] [Related]
19. Identification of two distinct tumor-suppressor loci on the long arm of chromosome 10 in small cell lung cancer.
Kim SK; Ro JY; Kemp BL; Lee JS; Kwon TJ; Hong WK; Mao L
Oncogene; 1998 Oct; 17(13):1749-53. PubMed ID: 9796705
[TBL] [Abstract] [Full Text] [Related]
20. MMTV-induced mutations in mouse mammary tumors: their potential relevance to human breast cancer.
Callahan R
Breast Cancer Res Treat; 1996; 39(1):33-44. PubMed ID: 8738604
[TBL] [Abstract] [Full Text] [Related]
